PET-pharmacokinetics of 18F-Octreotide: A comparison with 67Ga-DFO- and 86Y-DTPA-octreotide

Nuclear Medicine and Biology

Volumn 24, Issue 4, 1997, Pages 275-286

  Wester, Hans Jürgen ^b   Brockmann, Jörg ^c   Rösch, Frank ^c   Wutz, Walter ^c   Herzog, Hans ^c   Smith Jones, Peter ^a   Stolz, Barbara ^a   Bruns, Christian ^a   Stöcklin, Gerhard ^c  

^a Preclinical Research   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NONE

Author keywords

Fluorine 18; Gallium 67; Octreotide; Somatostatin receptors; Yttrium 86

Indexed keywords

FLUORINE 18; GALLIUM 67; OCTREOTIDE; OCTREOTIDE F 18; OCTREOTIDE GA 67; UNCLASSIFIED DRUG; YTTRIUM 86 PENTETATE OCTREOTIDE; DIAGNOSTIC AGENT; FLUORINE; GALLIUM; SOMATOSTATIN RECEPTOR; YTTRIUM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; PANCREAS ISLET CELL TUMOR; PHARMACOKINETICS; POSITRON EMISSION TOMOGRAPHY; RAT; ANIMAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG STABILITY; LEWIS RAT; MALE; TISSUE DISTRIBUTION;

ANIMALS; DRUG STABILITY; FLUORINE RADIOISOTOPES; GALLIUM RADIOISOTOPES; MALE; OCTREOTIDE; RATS; RATS, INBRED LEW; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; YTTRIUM RADIOISOTOPES;

EID: 0030611042     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00039-5     Document Type: Article

References (47)

1. Albert R., Marbach P., Bauer P., Briner U., Fricker G., Bruns C. et al. (1993) SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity. Life Sci. 53, 517-525.
2. Amherdt M., Patel Y. C. and Orci L. (1989) Binding and internalization of somatostatin, insulin and glucagon by cultured rat islet cells. J. Clin. Invent. 84, 412-417.
3. Anderson C. J., Pajeau T. S., Edwards W. B., Sherman E. L. C., Rogers B.E. and Welch M. J. (1995) In vitro and in vivo evaluation of copper-64-octreotide conjugates. J. Nucl. Med. 36, 2315-2325.
4. 1]-Octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabeling and in vitro validation. Life Sci. 49, 1583-1591.
5. Bakker W. H., Krenning E. P., Breeman W. H., Koper J. W., Kooij P. P., Reubi J. C. et al. (1990) Receptor scintigraphy with radioiodinated somatostatin analogue: Radiolabeling, purification, biologic activity and in vivo application in animals. J. Nucl. Med. 31, 1501-1509.
6. 1-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci. 49(22), 1593-1601.
7. Banks W., Schally A. V., Barrera C. M., Fasold M. B., Durham D. A., Csernus V. J. et al. (1990) Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. USA. 87, 6762-6766.
8. Behr T. M., Sharkey R. M., Juweit M., Aninipot R., Griffiths G. L. and Goldenberg D. M. (1995) Reduction of kidney uptake of radiolabeled monoclonal antibody (Mab) fragments: Preclinical and initial clinical results. 42nd Annual Meeting of the Society of Nuclear Medicine, J. Nucl. Med. 36, 19P.
9. 3]octreotide. Eur. J. Nucl. Med. 20, 1089-1094.
10. 1]octreotide. Eur. J. Nucl. Med. 21, 328.
11. Bruns C., Stolz B., Albert R., Marbach P. and Pless J. (1993) OctreoScan®111 for Imaging of a somatostatin receptor-positive islet cell tumor in rat. Horm. Metab. Res. Suppl. Ser. 27, 4-11.
12. Desreux J. F. (1980) Nuclear magnetic resonance spectroscopy of lanthanide complexes with a tetraacetic tetraaza macrocycle: Unusual conformation properties. Inorg. Chem. 19, 1319-1324.
13. Draznin B., Mehler P. S., Leitner J. W., Sussman K. E., Dahl R., Vatter R. et al. (1985) Localization of somatostatin receptors secretion vesicles in anterior pituitary cells and pancreatic islets. J. Receptor Res. 5, 83.
14. Draznin B., Sherman N., Sussman K. E., Dahl R. and Vatter R. (1985) Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells. Endocrinology 117, 960.
15. Fricker G., Dubost V., Schwab D., Bruns C. and Thiele C. (1994) Heterogeneity in hepatic transport of somatostatin analog octapeptides. Hepatology 20, 191-200.
16. 18F]fluorocarboxylic acids. Appl. Radiat. Isot. 45, 715.
17. 1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radio-labeling, in vitro validation and biodistribution in mice. Nucl. Med. Biol. 21, 819-825.
18. Guillaume M., Luxen A., Nebeling B., Argentini M., Clark J. C. and Pike V. W. (1991) Recommendations for fluorine-18 production. Appl. Radiat. Isot. 42, 749-762.
19. Hajri A., Bruns C., Marbach P., Aprahamian M., Longnecker D. S. and Damgé C. (1991) Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with octreotide. Eur. J. Cancer 27, 1247-1252.
20. Hinkle P., Perone M. and Schonbrunn A. (1981) Mechanism of thyroid hormone inhibition of thyrotropin-releasing hormone action. Endocrinology 108, 199.
21. 1-octreotide by isolated perfused rat liver. J. Nucl. Med. 34, 2025-2030.
22. Kimura N., Hayafuji C. and Kimura N. (1989) Characterization of 17-β-estradiol-dependent and -independent somatostatin receptor subtypes in rat anterior pituitary. J. Biol. Chem. 264, 7033.
23. Krenning E. P., Bakker W. H., Kooij P. P. M., Breeman W. A. P., Oei H. Y., de Jong M. et al. (1992) Somatostatin receptor scintigraphy with In-111-DTPA-D-Phe-1-octreotide in man: Metabolism, dosimetry and comparison with Iodine-123-Tyr-3-octreotide. J. Nucl. Med. 33, 652-658.
24. 125I-Tyr3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20, 716-731.
25. Lamberts S. W. J., Krenning E. P. and Reubi J. C. (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr. Rev. 12, 450-482.
26. Lemaire M., Azira M., Dannecker R., Marbach P., Schweitzer A. and Maurer G. (1989) Disposition of sandostatin, a new synthetic somatostatin analogue in rats. Drug Metab. Dispos. 17, 699-703.
27. Maina T., Stolz B., Albert R., Bruns C., Koch P. and Mäcke H. (1994) Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m. Eur. J. Nucl. Med. 21, 437-444.
28. Moi M. K. and Meares C. F. (1988) The peptide way to macrocyclic bifunctional chelating agents: Synthesis of 2-(p-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane N,N′,N″,N‴-tetraacetic acid and study of its yttrium(III) complexes. J. Am. Chem. Soc. 110, 6266-6267.
29. Morel G., Pelletier G. and Heisler S. (1986) Internalization and subcellular distribution of radiolabelled somatostatin-28 in mouse anterior pituitary tumor cells. Endocrinology 119, 1972-1979.
30. Morel G. (1994) Internalization and nuclear localization of peptide hormones. Biochem. Pharmacol. 47, 63-76.
31. Mentlein R., Buchholz C. and Krisch B. (1989) Binding and internalization of gold-conjugated somatostatin and growth hormone-releasing hormone in cultured rat somatotropes. Cell. Tissue Res. 258, 309.
32. 18F-labeled biotin. Nucl. Med. Biol. 20, 401-405.
33. Quadri S. M., Vriesendorp H. M., Leichner P. K. and Williams J. R. (1993) Evaluation of indium-111- and yttrium-90-labeled linker-immunoconjugates in nude mice and dogs. J. Nucl. Med. 34, 938-945.
34. Reichlin S. (1983) Somatostatin: First of two parts. N. Engl. J. Med. 309, 1495-1501.
35. Reichlin S. (1983) Somatostatin: Second of two parts. N. Engl. J. Med. 309, 1556-1563.
36. 3He,xn)-processes. Radiochimica Acta 61, 1-8.
37. Rösch F., Qaim S. M. and Stöcklin G. (1993) Production of the positron emitting radioisotopes for nuclear medical application. Appl. Radiat. Isot. 44, 677-681.
38. Rota Kops E., Herzog H., Schmid A., Holte S. and Feinendegen L. E. (1990) Performance characteristics of an eight-ring whole-body PET scanner. J. Assist Comput. Tomogr. 14, 437-445.
39. Sakamoto C., Goldfine I. D. and Williams J. A. (1984) The somatostatin receptor on isolated pancreatic acinar cell plasma membranes. J. Biol. Chem. 15, 9623.
40. Schonbrunn A. (1982) Glucocorticoids down-regulate somatostatin receptors on pituitary cells in culture. Endocrinology 110, 1147.
41. Seelig J., Nebel S., Ganz P. and Bruns C. (1993) Electrostatic and nonpolar peptide-membrane interactions: Lipid binding and functional properties of somatostatin analogues of charge 2 = +1 to 2 = +3. Biochemistry 32, 9714-9721.
42. Smith-Jones P. M., Stolz B., Bruns C., Albert R., Reist H. W., Fridrich R. and Mäcke H. R. (1994) Gallium-67/gallium-68-[DFO]-octreotide-A potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: Synthesis and radiolabeling in vitro and preliminary in vivo studies. J. Nucl. Med. 35, 317-325.
43. Srkalovic G., Cai R. Z. and Schally A. V. (1990) Evaluation of receptors for somatostatin in various tumors using different analogs. J. Clin. Endocrinol. Metab. 70, 661-669.
44. 1]octreotide, a new derivative with high affinity for somatostatin receptors. In: Technetium and Rhenium in Chemistry and Nuclear Medicine (Edited by Nicolini M., Bandoli G. and Mazzi U.), pp. 395-400. Cortina International, Raven Press, New York.
45. Stolz B., Smith-Jones P., Ruser G., Albert R., Briner U., Weckbecker G. et al. (1994) Somatostatin analogues for radiodiagnosis and radiotherapy of cancer. EUFEPS Symposium on Tumour Targeting with Radiolabelled Hormones and Antibodies. Symposium abstract, Nuremberg, Germany.
46. 18F]fluorobenzoate. Nucl. Med. Biol. 19, 275.
47. 18F-labeling agents. EUFEPS Symposium on Tumour Targeting with Radiolabelled Hormones and Antibodies. Symposium abstract, Nuremberg, Germany.